Robert J. Harman, DVM, CEO and Founder of Vet-Stem, Inc. Presents at PRP and Regenerative Medicine Symposium of The Orthobiologic Institute (TOBI)
Founder and CEO of Vet-Stem, Inc., a leading Regenerative Veterinary Medicine company, Robert J. Harman, DVM presented at The Orthobiologic Institute (TOBI) PRP (Platelet Rich Plasma) and Regenerative Medicine Symposium June 6-7 in Las Vegas. The Symposium with Cadaver Lab boasts over 20 lectures from world-renowned experts in biologics.
Dr. Harman will be presenting on The Future of Biologics: Signposts from Equine Therapies, drawing on a decade of experience developing new products in the Regenerative Veterinary Medicine industry with Vet-Stem, and overseeing the completion of more than 1,000 contract research projects for the development of veterinary and human biotechnology products over his entire career. More recently Dr. Harman brought to the veterinary market Vet-Stem's GenesisCS-2 PRP Kit. The kit is optimized for equine use, to provide a rich source of autologous growth factors and bio-scaffolding for use in an area of acute injury, mainly in tendons and ligaments.
Many human medicine practices of the future are first proven in veterinary medicine, with typical use of products and validation from animal data being the flagship for human approvals and protocols. Dr. Harman's company is leading its industry in science-based literature including peer-reviewed studies to prove efficacy and to identify best practices in Regenerative Veterinary Medicine.
TOBI was established to share best practices in cutting-edge PRP and regenerative medicine therapies, drawing global opportunities for physicians to connect within the rapidly growing field. It strives to raise the standards of education and training with intensive hands-on programs and world-class informational curriculums. Courses are intended for Physiatrists, Sports Medicine Physicians, Orthopedists, Rheumatologists and more; addressing areas of the body including shoulder, elbow, wrist/hand, hip, knee, ankle/foot.